Concepedia

Bryan A. Fiamengo

BA

3

Publications

135

Citations

3

H-Index

2012

Active since

Affiliations

AbbVie (United States)(Current)

Bryan A. Fiamengo is an author at AbbVie (United States) specializing in natural sciences, medicinal chemistry, and drug discovery.

Top concepts

Publications per year

2012–2015

3

Publications

3

Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol

Eric R. Goedken, M.A. Argiriadi, David Banach et al. · Journal of Biological Chemistry · 2015 · 96 citations · Full text

Design and synthesis of tricyclic cores for kinase inhibition

Stacy Van Epps, Bryan A. Fiamengo, Jeremy J. Edmunds et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 22 citations · Full text

, , +5

Structure activity optimization of 6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazines as Jak1 kinase inhibitors

Michael Friedman, Kristine E. Frank, Ana L. Aguirre et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 17 citations

, , +6

Rows per page

1–3 of 3